Skip to Content

GG 614 GG 614 (RANITIDINE 150 mg)

Pill imprint GG 614 GG 614 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 150 mg GG 614 GG 614
Ranitidine hydrochloride 150 mg GG 614 GG 614 Front
Ranitidine hydrochloride 150 mg GG 614 GG 614 Back
Ranitidine hydrochloride
GG 614
GG 614
150 mg
16.00 mm
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
corn starch
FD&C Blue No. 1
FD&C Red No. 40
FD&C Yellow No. 6
magnesium stearate
propylene glycol
silicon dioxide
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0337 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.